期刊文献+

罗哌卡因单独或复合肾上腺素上胸段硬膜外阻滞的麻醉效果和药动学

Efficacy and pharmacokinetics of ropivacaine with and without adrenaline used for upper thoracic epidural anesthesia
暂未订购
导出
摘要 目的:探讨罗哌卡因单独或复合肾上腺素上胸段硬膜外阻滞的麻醉效果和药动学特征.方法:20例美国麻醉医师协会病情估计分级(ASA)Ⅰ~Ⅱ级行乳腺肿瘤手术病人,随机分为罗哌卡因单用组(RP组)及其与肾上腺素合用组(RP+AD组)每组10例;均选择T3-4穿刺并置管,在2 min内RP组注入0.5%罗哌卡因1.3 mg·kg-1,RP+AD组注入加入1:200 000肾上腺素(5 mg·L-1)的0.5%罗哌卡因1.3 mg·kg-1.比较注药后2组感觉和运动阻滞特征,以高效液相色谱法测血浆罗哌卡因浓度,比较2组药动学参数.结果:2组麻醉效果均评定为优,2组感觉和运动阻滞指标,t1/2α,t1/2β,tmax,Cl和Vd比较差异均无显著意义(P>0.05),RP+AD组在10~360 min期间对应时刻的血浆RP浓度值低于RP组,差异有显著或非常显著意义(P<0.05或P<0.01),cmax和AUC0~t均低于RP组,差异有显著意义(P<0.05).结论:0.5%罗哌卡因上胸段硬膜外麻醉安全、有效,加1:200000肾上腺素对0.5%罗哌卡因麻醉效果无明显影响,但可降低罗哌卡因血药浓度,有利于减少全身毒性的风险. AIM :To investigate the anesthetic efficacy and pharmacokinetics of ropivacaine with and without adrenaline used for upper thoracic epidural anesthesia (UTEA). METHODS: Twenty female patients (ASA Ⅰ-Ⅱ) undergoing breast surgery were allocated into two groups: group RP (ropivacaine group, n = 10) and group RP + AD (ropivacaine with adrenaline group,n = 10). UTEA was performed at the T3-4 interspace by using epidural catherter. Patients of group RP and RP + AD received 0.5 % ropivacaine 1.3 mg · kg^-1 and 0.5 % ropivacaine 1.3 mg · kg^-1 plus adrenaline 5 mg · L^-1 epidurally in 2 min, respectively. The indexes for sensory and rooter blockades of both groups were compared, the total plasma concentration of ropivacaine was determined by high perform- ance liquid chromatography. RESULTS: The anesthetic efficacies in both groups were satisfactory. There were no significant differences in indexes of sensoryand moter blockas, t1/2α,t1/2β,tmax, Cl and Vd between both groups . The plasma concentration of ropivacaine in group RP + AD was lower than that in group RP at 10-360 min relation time-point (P 〈 0. 05 or P 〈 0.01). The cmax and AUC0-t of group RP + AD were lower than those of group RP (P 〈 0.01 ). CONCLUSION: 0.5 % ropivacaine for UTEA is safe and effective. Addition of adrenaline shows no significant improvement but can significantly decrease the systemic plasma concentration and cmax of ropivacaine, and thus reduce the toxicity from absorption of ropivacaine.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2005年第9期740-743,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 河南省科技攻关资助项目(0211043900)
关键词 罗哌卡因 肾上腺素 药动学 麻醉 硬膜外 麻醉效果 ropivacaine adrenaline pharmacokinetics anesthesia, epidural anesthetic efficay
  • 相关文献

参考文献6

  • 1张富军,邓小明.罗哌卡因的实验与临床研究进展[J].中国新药与临床杂志,2000,19(4):317-319. 被引量:57
  • 2张春燕,顾健,段金菊,钟蕾,李玉珍.反相高效液相色谱法测定人血清中的罗哌卡因[J].色谱,2002,20(1):56-58. 被引量:10
  • 3谢文钦,吴伟平,丁志荣,杨玉欣,庄秀琴.罗比卡因用于高位硬膜外麻醉的临床观察[J].临床麻醉学杂志,2001,17(9):501-502. 被引量:14
  • 4CHARLES EP, EMANUELSSON BM, REVENTLID H, et al. A comparison of the dynamics and pharmacokinetics of ropivacaine 7.5mg/ml with and without epinephrine used for epidural anaesthesia in urological surgery[J]. Clin Drug Invest, 2003,23(4): 245-253.
  • 5LEE BB, NGAN K, PLUMMER JL, et al. The effect of addition of epinephrine on early systemic absorption of epidural ropivacaine in humans[J]. Anesth Analg, 2002, 95 (5): 1402-1407.
  • 6ROELANTS FA, VEYCKEMANS F, VERBEECK RK, et al. Pharmacokinetics of caudal ropivacaine and with without epinephrine in children[J]. Anesthesiology, 2000, 3A:A 1269.

二级参考文献13

  • 1[1]Brockway MS,Bannister J,McClure JH,et al.Comparison of extradural ropivacaine and bupivacaine.Br J Anaesth,1991,66:31-37.
  • 2[2]Rosenberg PH,Kytta J,Alila A,et al.Absorption of bupivacaine etidocaine,lignocaine and ropivacaine into N-heptane,rat sciatic never and human extradural and subcutaneous fat.Br J Anaesth,1986,58:310-314.
  • 3Lee A,Fagan D,Lamont M,Tucker GT,Halldin M,Scott DB.Disposition kinetics of ropivacaine in humans[].Anesthesia and Analgesia.1989
  • 4Ekstrom G,Gunnarsson UB.Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P-450 1A and 3A in human liver microsomes[].Drug Metabolism and Disposition.1996
  • 5Valenzuela C,Delpon E,Franqueza L,Gay P,Snyders DJ,Tamargo J.Effects of ropivacaine on a potassium channel (hKv 1. 5) cloned from human ventricle[].Anesthesiology.1997
  • 6Hirota K,Browne T,Appadu BL,Lambert DG.Do local anaesthetics interact with dihydropyridine binding sites on neuronal Ltype Ca+ channels?[].British Journal of Anaesthesia.1997
  • 7Reiz S,Haggmark S,Johansson G,Nath S.Cardiotoxicity of ropivacaine———A new amide local anaesthetic agent[].Acta Anaesthesiologica.1989
  • 8Feldman HS,Arthur GR,Covino BG.Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine and lidocaine in the conscious dog[].Anesthesia and Analgesia.1989
  • 9Nancarrow C,Rutten AJ,Runciman WG,et al.Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep[].Anesthesia and Analgesia.1989
  • 10Johansson B,Glise H,Hallerback B,Dalman P,Kristoffersson A.Preoperative local infiltration with ropivacaine for postoperative pain relief after cholecystectomy[].Anesthesia and Analgesia.1994

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部